TR200907338A1 - A film strip containing natural ingredients. - Google Patents

A film strip containing natural ingredients.

Info

Publication number
TR200907338A1
TR200907338A1 TR2009/07338A TR200907338A TR200907338A1 TR 200907338 A1 TR200907338 A1 TR 200907338A1 TR 2009/07338 A TR2009/07338 A TR 2009/07338A TR 200907338 A TR200907338 A TR 200907338A TR 200907338 A1 TR200907338 A1 TR 200907338A1
Authority
TR
Turkey
Prior art keywords
containing natural
film strip
natural ingredients
strip containing
oral mucosa
Prior art date
Application number
TR2009/07338A
Other languages
Turkish (tr)
Inventor
Yeşi̇lada Erdem
Duman Gülengül
Original Assignee
Yedi̇tepe Üni̇versi̇tesi̇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yedi̇tepe Üni̇versi̇tesi̇ filed Critical Yedi̇tepe Üni̇versi̇tesi̇
Priority to TR2009/07338A priority Critical patent/TR200907338A1/en
Priority to PCT/IB2010/054121 priority patent/WO2011036599A1/en
Priority to EP10760438A priority patent/EP2482808A1/en
Priority to JP2012531521A priority patent/JP2013505981A/en
Publication of TR200907338A1 publication Critical patent/TR200907338A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu buluş, doğal ürün formulasyonları içeren ve ağız mukozasından emilebilen film şeritleri ile ilgilidir. Söz konusu film şeridi ağız mukozasından bilinen dozaj şekillerine göre daha düşük dozlarda uygulandığında hızla emilerek kısa sürede rahatsızlıkları önleme ve tedavi etme amaçlı kullanılabilmektedir.The present invention relates to film strips containing natural product formulations and which can be absorbed through the oral mucosa. When the said film strip is applied at lower doses than known dosage forms from the oral mucosa, it can be rapidly absorbed and used in a short time to prevent and treat ailments.

TR2009/07338A 2009-09-28 2009-09-28 A film strip containing natural ingredients. TR200907338A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2009/07338A TR200907338A1 (en) 2009-09-28 2009-09-28 A film strip containing natural ingredients.
PCT/IB2010/054121 WO2011036599A1 (en) 2009-09-28 2010-09-14 A dissolvable film strip comprising natural components
EP10760438A EP2482808A1 (en) 2009-09-28 2010-09-14 A dissolvable film strip comprising natural components
JP2012531521A JP2013505981A (en) 2009-09-28 2010-09-14 Dissolvable film strip with natural ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/07338A TR200907338A1 (en) 2009-09-28 2009-09-28 A film strip containing natural ingredients.

Publications (1)

Publication Number Publication Date
TR200907338A1 true TR200907338A1 (en) 2011-04-21

Family

ID=43297154

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/07338A TR200907338A1 (en) 2009-09-28 2009-09-28 A film strip containing natural ingredients.

Country Status (4)

Country Link
EP (1) EP2482808A1 (en)
JP (1) JP2013505981A (en)
TR (1) TR200907338A1 (en)
WO (1) WO2011036599A1 (en)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6393717A (en) 1986-10-09 1988-04-25 Sekisui Chem Co Ltd Sticking agent or adhesive agent for oral mucosa
IT1276225B1 (en) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ALKANOYL L-CARNITINE IN ASSOCIATION WITH RESVERATROL OR ITS DERIVATIVES USEFUL FOR
JP3370561B2 (en) * 1997-06-19 2003-01-27 典子 金城 How to extract melatonin
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
DE60031921T2 (en) * 1999-08-16 2007-09-20 Dsm Ip Assets B.V. Process for the preparation of epigallocatechin gallate
JP2001097872A (en) * 1999-09-30 2001-04-10 Api Co Ltd Red wine extract and method of its production
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US20040156895A1 (en) * 2002-11-12 2004-08-12 Elan Pharma International Ltd. Solid dosage forms comprising pullulan
WO2005082407A1 (en) * 2003-11-03 2005-09-09 Musc Foundation For Research Development Use of quercetin and resveratrol to treat and prevent oral cancer
CN100366294C (en) * 2004-04-30 2008-02-06 量子高科（北京）研究院有限公司 Oral cavity quick dissolving preparation and production method thereof
KR100874802B1 (en) * 2004-06-22 2008-12-19 이-엘 매니지먼트 코포레이션 Soluble film composition
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
BRPI0807943A2 (en) * 2007-02-15 2014-10-21 Derma Young Ltd PHARMACEUTICAL OR NUTRATIC COMPOSITION AND METHODS FOR IMPROVING ADMINISTRATION OF A PHARMACEUTICAL INGREDIENT FOR ORAL MUCOSA AND FOR APPETITE SUPPRESSION
US20080220029A1 (en) * 2007-03-05 2008-09-11 Charlene Ng Fast-dissolving/disintegrating film preparation having high proportion of active
MX2009010878A (en) * 2007-04-11 2010-03-26 John A Mccarty Melatonin tablet and methods of preparation and use.
JP2008303153A (en) * 2007-06-05 2008-12-18 Tsukioka:Kk Crude drug preparation
US20090004254A1 (en) 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
US20100261784A1 (en) * 2007-12-07 2010-10-14 Fujifilm Corporation Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
US20090175803A1 (en) * 2008-01-08 2009-07-09 David Rubin Method and compositions for administering resveratrol and pterostilbene

Also Published As

Publication number Publication date
EP2482808A1 (en) 2012-08-08
WO2011036599A1 (en) 2011-03-31
JP2013505981A (en) 2013-02-21

Similar Documents

Publication Publication Date Title
CY1123470T1 (en) IBAT INHIBITORS FOR THE TREATMENT OF HEPATOPATHIES
PH12017501306A1 (en) Inhibitors of histone demethylases
CY1114988T1 (en) BROMODOMAIN BENZODIAZEPIN RISK
CO6551683A2 (en) TREATMENT FOR GASTROINTESTINAL DISORDERS
UA111343C2 (en) Pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride
EA201500742A1 (en) PHARMACEUTICAL COMPOSITIONS PROTECTED FROM NON-GOAL USE
CL2017003066A1 (en) Compositions of amorphous calcium carbonate for administration by inhalation, sublingual or buccal
CY1115081T1 (en) NEW EXTRACT FROM GAIDOURAGATHO, METHOD FOR PREPARATION AND USE
EA200802324A1 (en) NEW FORM FOR THE INTRODUCTION OF THE RACECADOTRIAL
NZ702930A (en) Racecadotril liquid compositions
CR11744A (en) LIQUID FORMULATION FOR DEFERIPRONE WITH NICE TASTE TO THE PALATE
UY33530A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES
MX2015007678A (en) Transmucosal delivery of glatiramer acetate.
BR112014004577A2 (en) pi3k inhibitor for use in treating bone cancer or for metastatic prevention of primary bone cancer cells
EA201171414A1 (en) IAP FAMILY INHIBITORS
EA201200485A1 (en) ORAL FALLING PHARMACEUTICAL DRUG FORM CONTAINING AIPIPRAZOL
CY1122935T1 (en) GLYCOGEN-BASED WATER SOLUBILITY ENHANCER
TR200900879A2 (en) Pharmaceutical compositions in which the active ingredients are combined in a single dosage form
TR201819662T4 (en) Orally dispersible film composition containing enalapril for the treatment of childhood hypertension.
EA201590678A1 (en) CONNECTIONS FOR THE TREATMENT OF THE BLOCADE OF REMIELINIZATION IN DISEASES RELATED TO THE EXPRESSION OF THE PROTECTIVE PROTEIN
MD4475B1 (en) Use of an oral formulation for the treatment of cardiovascular diseases
TR201007250A2 (en) Formulation containing cellobiose.
TR200907338A1 (en) A film strip containing natural ingredients.
TR201101884A2 (en) A film strip containing natural ingredients.
TR201101887A2 (en) A Filmstrip Containing Natural Ingredients.